Background: High fluid volumes may increase neonatal morbidity. However, evidence supporting fluid restriction is inconclusive and restricting fluids may restrict caloric intake.
Introduction
Evidence exists to suggest that fluid balance in the first days to weeks of life is an important factor influencing neonatal morbidity. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] It is believed that this becomes increasingly important in extremely low birth weight (ELBW) infants where the margin for error is reduced. Yet precise guidelines for fluid therapy in ELBW infants have not been clearly defined. Previous authors have recommended restricting the amount of fluid given to these tiny infants to allow for a negative water balance in the first few days of life. 1,2,5,6,8,9,11 -18 These recommendations are based on the belief that over-hydration is associated with increased risk for morbidities, including bronchopulmonary dysplasia (BPD) and patent ductus arteriosus (PDA). [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] However, the evidence supporting fluid restriction is conflicting and inconclusive. Although fluid restriction is a common practice in our neonatal intensive care unit (NICU), it is a practice that differs widely among physician staff, resulting in a large variation in the amount of fluid given to infants. This variation in practice is based on differences in staff opinions regarding the risk of fluid administration, as well as differences in the use of birth weight versus current weight to calculate fluid administered during the first week of life. Therefore, we took this opportunity to evaluate the effect of varying fluid intake on the incidence of PDA and BPD.
Nutritional status is also an important factor influencing the immediate and long-term morbidity of ELBW infants. There is some concern that fluid restriction may inadvertently limit caloric intake, thus providing inadequate calories to these already tiny infants. Although the true nutritional requirements for ELBW infants remains unknown, evidence in support of adequate nutrition is convincing. 19, 20 It has been shown that adequate nutrition is crucial in reducing the risk and severity of BPD. 21, 22 The failure to provide adequate caloric intake results in a catabolic state that can lead to diaphragmatic muscle fatigue. In addition, adequate nutrition plays a major role in lung growth, lung alveolar development, lung function including surfactant production, lung repair and defense against infection. 22 On the basis of published data, the American Academy of Pediatrics Committee on Nutrition initially released recommendations on the nutritional needs of low birth weight infants in 1985. 23 The recommendations state that energy intakes of 120 to 130 kcal kg À1 day À1 are required for normal rates of growth (15 g kg À1 day À1 ) in healthy, growing low birth weight infants at 3 to 4 weeks of age. Providing this caloric load routinely requires fluid administration of at least 150 ml kg À1 day À1 of fluid. However, it is unknown whether caloric intake of less than 120 to 130 kcal kg À1 day À1 is adequate to achieve growth during the first 3 to 4 weeks of life. It is not clear whether careful management of nutritional intake can result in the provision of adequate calories when fluid administration is below 150 ml kg À1 day À1 ; and it is not known if fluid rates needed to provide these calories are harmful.
The primary objective of this study was to determine if regimens for fluid therapy used in our NICU were associated with an increased risk of morbidity from BPD or PDA in infants born p 1250 g birth weight. The second objective was to determine if fluid restriction can be practiced in these infants, without significantly limiting caloric intake.
We hypothesized that infants in our NICU born p1250 g birth weight who receive higher volumes of fluid in the first 4 weeks of life are at increased risk of developing BPD and PDA and that, due to careful management of nutritional intake in our NICU, infants receive similar caloric intake in the first weeks of life regardless of fluid intake.
Study design
We performed a chart review of a cohort of 208 appropriate for gestational age infants who were born p32 weeks gestational age and p1250 g birth weight, admitted to our NICU between January 1, 2000, and December 31, 2001 , and survived to discharge. Four infants were excluded from the cohort, three due to missing data (one early discharge to a level 2 NICU before 1 week of age, one late admission transferred from an outside hospital at 2 days of life and one missing chart) and one due to a congenital anomaly (duodenal atresia), for a final sample size of 204 infants. The following data were collected: birth weight, gestational age, gender and race; daily weights; daily parenteral and enteral fluid and caloric intake for the first 28 days of life; illness severity scores at 24 h of life; and the presence of BPD or PDA.
Weight, fluid intake and caloric intake were collected daily for the first 28 days of life. Daily change in weight over the previous 24 h was calculated. Fluid and caloric intake on days 1 to 7 was analyzed individually by day and averaged as week 1. Days 8 to 14, 15 to 21 and 22 to 28 intakes were averaged as weeks 2, 3 and 4, respectively.
The score for neonatal acute physiology (SNAPPE-II), 24 an illness severity score developed to predict neonatal mortality, was calculated at 24 h of life. This score includes assessment of perinatal risk factors, including birth weight, small for gestational age versus appropriate for gestational age status, and 5 min Apgar score, as well as physiologic risk factors, including lowest mean arterial blood pressure, lowest temperature, lowest PaO 2 /FiO 2 ratio, lowest serum pH, urine output and presence of multiple seizures. The SNAPPE-II score has been validated for a large, diverse population of newborns admitted to the NICU with a variety of birth weights. Scores range from 0 to 222 and higher scores indicate more severe illness.
Morbidities were defined using standard published definitions. Infants were diagnosed with BPD if they were still receiving oxygen at 36-weeks corrected age. PDA was defined as the presence of a symptomatic PDA diagnosed on clinical examination or by echocardiogram. All clinically significant PDAs were treated with indomethacin or surgical ligation. All infants in this cohort received prophylactic indomethacin at a dose of 0.1 mg per kg per dose every 12 h times 3 doses beginning in the first 12 h of life.
Infants were grouped into three groups of fluid administration (low, intermediate and high) by day and week of life. Infants receiving a total fluid volume on a given day or week that was less than the twenty-fifth centile were assigned to the low-fluid-intake group, infants receiving more than the seventy-fifth centile were assigned to the high-intake group and infants between the twentyfifth and seventy-fifth centiles were assigned to the intermediateintake group. Clinically, these fluid groups corresponded to actual fluid volumes (ml kg À1 day À1 ) as shown in Table 1 . Pearson's w 2 tests were used to test differences in proportions of subjects with or without morbidities, across low, intermediate-and high-fluid groups, on days 1 to 7 and weeks 1 to 4 of life. w 2 for trend was also used to test for a significant linear increase in morbidities across fluid groups. Analysis of variance tested differences in daily caloric intake across groups. Logistic regression models were performed to explore the relationship between fluid intake and morbidities while controlling for gestational age and illness severity as measured by 24 h SNAPPE-II score. An attempt to control for fluid balance was made by adding daily weight change (measured in g per kg of body weight per day) to the regression models. To avoid colinearity, birth weight was not controlled for separately in the models because it is a factor included in the SNAPPE-II score. Fluid intake was entered into the models as a continuous variable, which allowed for more precision and statistical power. Thus, odds ratios represent odds of morbidity associated with each 1 ml kg À1 day À1 increase in fluid intake. The study was approved by the Women and Infants' Hospital Institutional Review Board. Informed consent was not obtained. Fluid regimens in first week of life increase risk of PDA BE Stephens et al
Results
The average birth weight of the 204 ELBW infants was 937 g (±191 g) with a range of 540 to 1250 g. Average gestational age was 27 weeks ± 2 with a range of 23 to 31 weeks. Forty-seven percent of the cohort was male, 70% white, 14% black, 10% Hispanic and 6% Asian or Pacific Islander. Infant characteristics of the three fluid groups for week 1 of life are shown in Table 2 . Average birth weights and gestational ages were significantly lower in the high-fluid group than those in the intermediate-and low-fluid group. SNAPPE-II scores were significantly higher in the high-fluid group. The percentage of males in each group was similar. Infants in the low-fluid group had significantly lower average daily weight loss during week 1 than infants in the intermediate or high-fluid group.
Within the total cohort, 31% of infants developed BPD and 10% developed PDA. As shown in Table 3 , fluid intake on days 1, 2 and 3 and week 1 was significantly associated with rates of BPD on bivariate analysis. Twenty percent of infants in the low-fluid group on day 1, 26% of infants in the intermediate-fluid group and 53% of infants in the high-fluid group went on to develop BPD. Similar results were seen on days 2, 3 and week 1 of life.
Fluid intake on days 1, 2 and 3 and week 1 of life was also significantly associated with rates of PDA (Table 3) . Only 2% of infants in the low-fluid group and 6% in the intermediate-fluid group on day 1 developed PDA. Yet 25% of infants in the high-fluid group on day 1 went on to develop a clinically significant PDA requiring treatment. Fluid intake on days 4 to 7 and weeks 2 to 4 of life was not significantly associated with rates of BPD or PDA (data not shown).
Regression models were performed to determine the association of total fluid intake (ml kg À1 day À1 ) on days 1 to 3 and week 1 with PDA and BPD while controlling for gestational age at birth, illness severity as measured by SNAPPE-II score at 24 h of age and mean daily weight change (g kg À1 day À1 ) on days 1 to 3 and for week 1. Fluid intake on days 2 and 3 of life had an independent contribution to risk of PDA, with odds ratios of 1.014 (95% confidence interval 1.001 to 1.028) and 1.022 (95% confidence interval 1.004 to 1.040), respectively (Table 4) . For every 1 ml/kg increase in fluid given on day 2 of life, the odds of developing a PDA are increased by 1.4%, and on day 3 by 2.2%. Thus, for each 10 ml/kg increase in fluid on days 2 and 3, the odds of developing PDA are increased by 14 and 22%, respectively (1.4 Â 10 ¼ 14). SNAPPE-II scores provided an independent contribution to PDA. Neither gestational age nor weight loss/gain was associated with PDA. In a similar regression model, fluid intake did not contribute significantly to risk of BPD when controlling for confounding variables (model not shown).
We performed a post hoc analysis to explore whether a threshold for daily fluid administration exists above which the risk of PDA increases significantly. Infants were grouped into deciles of fluid intake. Pearson's w 2 tests were again used to test differences in the proportions of infants with PDA across decile groups. As shown in Table 5 , a significant increase in the rate of PDA was identified in infants in the highest decile of fluid administration during the first week of life, compared to the lower nine deciles. Similar results were seen when each of the first 7 days of life was analyzed individually. This provided cutoff points for fluid administration as shown in Table 6 . Intake of greater than 146 ml kg À1 day À1 on day 1 was associated with a 25% rate of PDA compared to an 8% rate in infants receiving less than 146 ml kg À1 day À1 (P ¼ 0.016). After day 1, the top 10% of fluid administered corresponded to greater than at least 170 ml kg À1 day À1 and was associated with significantly higher rates of PDA on all but days 4 and 5 of life.
Regression models were again performed to determine the association of top decile fluid intake (ml kg À1 day
À1
) on days 1 to 3 and week 1 with PDA while controlling for gestational age at birth, illness severity as measured by SNAPPE-II score at 24 h of n (%). )-fluid groups (P ¼ 0.3631). There were also no differences seen in caloric intake across decile groups.
Discussion
The results of this study suggest that low to intermediate fluid intake in the first 3 days of life is protective for PDA. Average birth weights and gestational ages were significantly lower and SNAPPE-II scores were significantly higher in the high-fluid group than those in the intermediate-and low-fluid groups. These differences correspond to what is seen in clinical practice. Infants in the lower fluid group had lower average daily weight loss, which is counterintuitive based on fluid intake, but logical clinically as infants in this group were larger, more mature infants with less insensible losses. Smaller, more preterm infants have a higher surface area to body weight ratio and a more immature epidermis, resulting in higher insensible losses and the need for more fluid to replace these losses and prevent dehydration. 25 Sicker infants are often hemodynamically unstable, requiring fluid boluses and/or blood products to maintain blood pressure and perfusion of vital organs. In addition, infants with lower birth weight and gestational age are at higher risk of BPD and PDA. In our study, only the association between high fluid intake on days 2 and 3 of life and risk of PDA remained after controlling for gestational age and severity of illness as measured by the SNAPPE-II score.
Although over-hydration has been implicated in the development of both BPD and PDA, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] it is not clear from prior studies whether complications arising from excessive hydration are due to fluid therapy itself, to an increase in total body water resulting from decreased renal losses or an increase in extracellular water volume due to third spacing. 6 To address this question, regression models were run that included weight change in grams per kg of body weight per day. In these models, fluid intake remained an independent predictor of PDA. This suggests that high fluid administration itself, regardless of fluid balance, increases PDA risk.
By comparing the infants across deciles of fluid administration we were able to establish a threshold of fluid administration above which the risk of PDA appears to increase significantly. These Fluid regimens in first week of life increase risk of PDA BE Stephens et al thresholds were higher than expected, at 146 ml kg À1 day À1 on day 1 and over 170 ml kg À1 day À1 for the remainder of the first week of life. When regression models were performed to control for confounding variables, fluid intake >170 ml kg À1 day À1 on day 3 alone remained associated with increased risk of PDA. This would suggest that fluid restriction to less than 170 ml kg À1 day À1 is unnecessary.
On the other hand, previous concern that lower fluid intake may result in lower caloric intake was not supported. Caloric intake across groups was almost identical, suggesting that even when fluid rates are restricted to less than 126 ml kg À1 day À1 during the first week of life, caloric intake is not compromised. This is attributed to nutritionists who order the parenteral infusions and maximize caloric and nutrient density to compensate for fluid restriction. All infants in this NICU are started on day 1 with a glucose load of 4 to 6 mg kg À1 min À1 and advanced by 1 mg kg À1 min À1 each day if serum glucose is 80 to 120. Protein and lipids are also started and advanced in predictable ways regardless of fluid intake. This results in similar caloric intake for all ELBW infants during the first week of life.
Caloric intake in our population was lower than published recommendations of 120 to 130 kcal kg À1 day
À1
, a goal usually achieved by the second week of life. When fed parenterally during the first week of life, however, the resting metabolic rate for ELBW infants in a thermoneutral environment is approximately 40 kcal kg À1 day À1 . 26 Additional non-growth-related energy needs may be 10 to 20 kcal kg À1 day À1 . If growth has not started in the first week, then 61 to 63 kcal kg À1 day À1 may be enough to support infants' initial basic needs while nutrient and energy intakes are advanced over time to meet the standards for healthy, growing premature infants.
Several prior retrospective and observational studies reveal an increased risk of PDA, 2,8 BPD 2-5,10,11 and mortality, 10 in infants given high fluid volumes in the first 3 to 5 days of life and in infants who do not diurese or lose weight within the first 3 days of life. 4, 7, 11, 12 However, other observational studies have shown no difference in the early fluid regimens (first 4 to 14 days) of infants who develop BPD 27 or PDA 16, 17 compared to those who do not. To date, only four prospective randomized controlled trials have been performed to assess the risks of high versus low fluid intake in very low birth weight infants. 1, 9, [28] [29] [30] These trials were summarized in a Cochrane review in 2001. 31 Three of these studies found no difference in rates of PDA or BPD in infants randomized to receive high or low fluid intakes. 9,28 -30 In only one of these studies, infants who received 'high' fluid volumes (>169 ml kg À1 day À1 ) were found to have a higher risk of PDA, congestive heart failure and necrotizing enterocolitis, but not of BPD. 1 Our study supports the previous findings that after controlling for illness severity, increased fluid intake is not significantly related to BPD.
A limitation of our study is its retrospective design. Strengths are its large sample size, the largest (n ¼ 204) published to date and its inclusion of the most preterm cohort of infants at the highest risk for BPD and PDA. It is also the first study to control for illness severity, gestational age and fluid balance when assessing the effects of fluid intake on rates of morbidities. A threshold of fluid administration in the first few days of life was identified within our cohort, above which the risk of PDA increases significantly. Finally, this fluid study is the first to demonstrate that similar caloric intake can be achieved with low, intermediate and high fluid administration.
Conclusions
Fluid intake does not predict the development of BPD when controlling for other known risk factors. After controlling for gestational age and illness severity, high fluid intake on days 2 and 3 of life remains a significant predictor of PDA. Fluid intake above 170 ml kg À1 day À1 on day 3 of life is associated with increased risk of PDA among infants p1250 g. Similar caloric intake can be achieved when fluid intake is less than 126 ml kg À1 day À1 during the first week of life. Thus, careful attention should be paid to fluid management of ELBW infants, but data to support fluid restriction are not convincing.
